Viridian Therapeutics Ors Inc (VRDN)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
VRDN Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
VRDN Quarterly Cost of Revenue ($668.97K → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
VRDN cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 320,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 39,317,000 | |
| 22,119,000 | |
| 21,712,000 | |
| 17,746,000 | |
| 22,394,000 | |
| 8,121,000 | |
| 12,565,000 | |
| 13,806,000 | |
| 15,254,000 | |
| 0 | |
| 0 | |
| 0 | |
| 6,417,000 | |
| 9,027,000 | |
| 8,599,000 | |
| 8,751,000 | |
| 8,234,000 | |
| 7,399,000 | |
| 8,375,000 | |
| 6,413,000 | |
| 4,998,000 | |
| 5,018,000 | |
| 5,487,000 | |
| 4,120,000 | |
| 692,000 | |
| 599,000 | |
| 628,000 | |
| 629,000 | |
| 456,000 | |
| 577,000 | |
| 678,000 | |
| 760,000 | |
| 909,784 | |
| 871,522 | |
| 675,731 | |
| 663,514 | |
| 388,617 | |
| 713,200 | |
| 603,054 | |
| 668,967 |